Anthony Hagen
Advertisement
Articles by Anthony Hagen
The FDA will reassess 6 indications for immune checkpoint inhibitors that were granted accelerated approval but failed to prove clinical benefit in confirmatory trials.
Advertisement
Latest Updated Articles
Conference Coverage: European Hematology Association 2021 Virtual CongressPublished: August 17th 2021 | Updated:
- For Staying Power, Diabetes Interventions May Need a Hands-on Element
Published: January 21st 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
2
Real-World Data Highlight Value of NOTCH1 Screening in CLL
3
Accountable Care: Not Just for the Healthiest Patients
4
Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB
5
